期刊文献+

Apelin-13对糖尿病大鼠心肌代谢的影响 被引量:2

Effects of apelin-13 on myocardium metabolism in diabetic rats
原文传递
导出
摘要 目的观察外源性给予Apelin-13对糖尿病大鼠心肌细胞代谢的影响。方法40只雄性Wister大鼠随机分成对照组8只,实验组32只。实验组通过高糖高脂饮食联合小剂量腹腔注射链脲佐菌素(STZ)构建2型糖尿病大鼠模型。造模成功的糖尿病大鼠随机分成糖尿病模型组14只,Apelin-13给药组14只。给药组给予Apelin-13 0.1μmol·kg-1·d-1腹腔注射,对照组和糖尿病模型组给予0.9%氯化钠溶液等体积腹腔注射,连续给药10周。10周末,测定大鼠空腹血糖后取材。酶联免疫吸附实验(EuSA)测定血清、心肌游离脂肪酸(FFA),免疫组化法比较各组大鼠心肌葡萄糖转运蛋白4(GLUT4)表达,实时荧光定量PCR检测心肌组织中过氧化物酶体增生物激活体-α(PPARα)、脂肪酸转运蛋白CD36、肉碱脂酰转移酶-1(CPT-1)等基因mRNA的表达。结果糖尿病模型组大鼠空腹血糖、血清FFA、心肌FFA水平升高(均P〈0.05),给予Apelin-13干预后,大鼠空腹血糖、心肌FFA水平较模型组下降,血清FFA水平下降不明显。糖尿病模型组和Apelin-13给药组心肌细胞PPARα、CD36、CPT-1 mRNA的基因相对表达水平较对照组升高(P〈0.05),经Apelin-13治疗后,给药组心肌细胞PPARd、CD36、CPT-1 mRNA的基因相对表达水平较糖尿病模型组下降(P〈0.05)。心肌细胞GLUT4表达在糖尿病模型组(1.138±0.316)和Apelin-13给药组(4.631±1.832)较对照组(9.132±2.156)下降(F=65.507,P%0.05),Apelin-13给药组较糖尿病模型组表达升高(P〈0.05)。结论Apelin-13增加心肌葡萄糖转运蛋白4表达,增加游离脂肪酸的利用,同时能够有效地降低PPARa、CD36、CPT-1的表达,在一定程度上改善糖尿病大鼠心肌代谢。 Objectives To investigate the effects of Apelin-13 on myocardial metabolism in diabetic rats. Methods A total of 40 male Wister rats were randomly divided into normal control group (NC,n=8) and experimental group (n= 32). Diabetic rats model were induced by high-sugar and high-fat diet combined with low-dose intraperitoneal injection of streptozotocin (STZ). The well- established 28 diabetic model rats were randomly divided into diabetic model group (DM,n= 14) and apelin-13 treated group (n = 14). In the Apelin-13 group, diabetic rats were administered Apelin-13 [0.1 μmol/(kg·d)]by intraperitoneal injection for 10 weeks, while the control group and diabetic model group were given an equal volume of 0.9% NaCl. At the end of the 10th week,all rats were sacrificed after fasting glucose measurement. Levels of serum free fatty acids (FFA) and myocardial FFA were measured by ELISA. Expression of myocardial glucose transporter member 4 (GLUT4) were detected by immunohistochemistry. The mRNA expressions of myocardial PPARa, CD36 and CPT-1 were detected by real time fluorescence quantitative PCR. Results Fasting blood glucose, serum FFA and myocardial FFA were significantly higher in DM group than in NC group (all P〈0.05). The level of plasma glucose and myocardial FFA were significant lower(P〈0.05) in Apelin-13 treated group than in DM group; but serum FFA was not significantly lower(P〈0.05). The mRNA expressions of PPARa, CD36, CPT-1 in cardiac myocyte were higher in DM group and Apelin-13 treated group than in control(P〈0.05) ,and lower in Apelin-13 treated group than in DM group(P〈0.05). The expression of myocardial GLUT4 was significantly lower in DM group(1. 138±0. 316)and in Apelin-13-treated group (4. 631±1. 832 ) than in NC group (9. 132 ± 2. 156 ), (F = 65. 507, P〈0.05) ,and higher in Apelin-13-treated group than in DM group(P〈0.05). Conclusions Apelin-13 increases myocardial expression of GLUT4,improves utilization of FFA
作者 杜孟泽 冯景辉 赵航 路英 吴秀萍 Du Mengze Feng Jinghui Zhao Han Lu Ying Wu Xiuping(Department of Geriatrics ,First A f filiated Hospital of Harbin Medical University, Harbin 150001 , China Department of Endocrinology, Hebei Province's People Hospital, Shij iazhuang 050055, China)
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2017年第4期454-458,共5页 Chinese Journal of Geriatrics
基金 哈尔滨市科技创新人才研究专项资金项目(2012RFXXSO50) 哈尔滨医科大学附属第一医院科研基金(2016Y007)
关键词 APELIN-13 糖尿病 能量代谢 心肌 Apelin-13 Diabetes mellitus Energy metabolism Myocardium
  • 相关文献

参考文献2

二级参考文献31

  • 1KharroubiAT, Darwish HM. Diabetes mellitus: The epidemic of the century[J]. World J Diabetes, 2015,6(6) ..850-867. DOI: 10. 4239/wjd. v6. i6. 850. 被引量:1
  • 2Asrih M, Steffens S. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy [ J ]. Cardiovase Pathol, 2013,22(2) : 117 125. DOI.. 10. 1016/j. carpath. 2012.07. 004. 被引量:1
  • 3Zhengzhong Z, Yafa Y, Jin L. Fibrinogen like protein 2 gene silencing inhibits cardiomyocytes apoptosis, improves heart function of streptozotocin- induced diabetes rats and the molecular mechanism involved[J]. Biosci Rep, 2015, 35: e00219. DOI..10. 1042/BSR20150078. 被引量:1
  • 4KuetheF, Sigusch HH, Bornstein SR, et al. Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? [J]. Horm Metab Res,2007,39(9) :672-676. DOI: 10. 1055/s-2007-985823. 被引量:1
  • 5Takemura G, Kanoh M, Minatoguchi S, et al. Cardiomyocyte apoptosis in the failing heart-a critical review from definition and classification of cell death [J]. Int J Cardiol, 2013, 167(6):2373-2386. D()I: 10. 1016/j. ijcard. 2013.01. 163. 被引量:1
  • 6AkcIlar R, Turgut S, Caner V, et al. The effects of apelin treatment on a rat model of type 2 diabetes[J]. Adv Med Sci, 2015,60(1):94-100. DOI: 10. 1016/j. advms. 2014.11. 001. 被引量:1
  • 7Castan-Laurell I, Dray C, Attan C, et al. Apelin, diabetes, and obesity [ J ]. Endocrine, 2011,40 ( 1 ) : 1 9. DOh 10. 1007/s12020-011-9507 9. 被引量:1
  • 8Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications[J]. Arq Bras Cardiol, 2008, 90 (5) : 343-379. DOI: 10. 1590/S0066- 782X2008000500012. 被引量:1
  • 9Dalzell JR, Rocchiccioli JP, Weir RAP, et al. The emerging potential of the apelin-APJ system in heart failure[J]. J Card Fail, 2015,21(6):489 449. DOI: 10. 1016/j. cardfail. 2015.03. 007. 被引量:1
  • 10B/icklund T, Palojoki E, Saraste A, et al. Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes[J]. Diabetologia, 2004,47(2) : 325-330. DOI: 10. 1007/s00125 003-1311-5. 被引量:1

共引文献12

同被引文献8

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部